Next Article in Journal
Topic Analysis of UK Fitness to Practise Cases: What Lessons Can Be Learnt?
Next Article in Special Issue
The Use of Primary Care Electronic Health Records for Research: Lipid Medications and Mortality in Elderly Patients
Previous Article in Journal
Impact of a Pharmacy-Led Transition of Care Service on Post-Discharge Medication Adherence
Previous Article in Special Issue
Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health
 
 
Article

Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing

1
Guy’s and St Thomas’ NHS Foundation Trust, London SE1 7EH, UK
2
NHS Specialist Pharmacy Service, London North West University Healthcare NHS Trust, London HA1 3UJ, UK
*
Author to whom correspondence should be addressed.
Pharmacy 2019, 7(3), 129; https://doi.org/10.3390/pharmacy7030129
Received: 1 June 2019 / Revised: 14 August 2019 / Accepted: 22 August 2019 / Published: 3 September 2019
(This article belongs to the Special Issue Deprescribing of Problematic Polypharmacy)
Deprescribing is complex and multifactorial with multiple approaches described in the literature. Internationally, there are guidelines and tools available to aid clinicians and patients to identify and safely withdraw inappropriate medications, post a shared decision-making medicines optimisation review. The increase in available treatments and use of single disease model guidelines have led to a healthcare system geared towards prescribing, with deprescribing often seen as a separate activity. Deprescribing should be seen as part of prescribing, and is a key element in ensuring patients remain on the most appropriate medications at the correct doses for them. Due to the complex nature of polypharmacy, every patient experience and relationship with medications is unique. The individual’s history must be incorporated into a patient-centred medication review, in order for medicines to remain optimal through changes in circumstance and health. Knowledge of the law and appropriate recording is important to ensure consent is adequately gained and recorded in line with processes followed when initiating a medication. In recent years, with the increase in interested clinicians globally, a number of prominent networks have grown, creating crucial links for both research and sharing of good practice. View Full-Text
Keywords: deprescribing; shared decision making; person-centred; medicines optimisation deprescribing; shared decision making; person-centred; medicines optimisation
Show Figures

Figure 1

MDPI and ACS Style

Le Bosquet, K.; Barnett, N.; Minshull, J. Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing. Pharmacy 2019, 7, 129. https://doi.org/10.3390/pharmacy7030129

AMA Style

Le Bosquet K, Barnett N, Minshull J. Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing. Pharmacy. 2019; 7(3):129. https://doi.org/10.3390/pharmacy7030129

Chicago/Turabian Style

Le Bosquet, Katherine, Nina Barnett, and John Minshull. 2019. "Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing" Pharmacy 7, no. 3: 129. https://doi.org/10.3390/pharmacy7030129

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop